We are live on !
Find out more
Bourgeon Capital Management Portfolio holdings
AUM
$696M
Turnover
22.13%
1-Year Est. Return
39.92%
This Fund
S&P 500
This Quarter Est. Return
+1.49%
1 Year Est. Return
+39.92%
3 Year Est. Return
+120.98%
5 Year Est. Return
+130.75%
10 Year Est. Return
+521.64%
AUM
$696M
AUM Growth
+$17.2M
(+2.5%)
Cap. Flow
+$21.2M
Cap. Flow % of AUM
Cap. Flow %
3.05%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
122
New
18
Increased
47
Reduced
36
Closed
9
Avg Time Held
Equity + Options
3.3
years
Top 10 Avg Time Held
Equity + Options
2.6
years
Top 20 Avg Time Held
Equity + Options
3.4
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.6
years
Top 20 Avg Time Held Equity only
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$10.6M |
| 2 |
Expand Energy Corp
EXE
|
+$10.3M |
| 3 |
NXP Semiconductors
NXPI
|
+$5.88M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$4.3M |
| 5 |
Qualcomm
QCOM
|
+$3.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$12M |
| 2 |
Primoris Services
PRIM
|
+$7.22M |
| 3 |
Vistra
VST
|
+$4.84M |
| 4 |
Illumina
ILMN
|
+$3.45M |
| 5 |
MongoDB
MDB
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.28% |
| 2 | Healthcare | 17.68% |
| 3 | Industrials | 14.22% |
| 4 | Financials | 13.36% |
| 5 | Materials | 6.59% |
Similar funds
IIA
MAA
SVCM
Bourgeon Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Bourgeon Capital Management held 122 positions worth $696M, up 2.5% from $679M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bourgeon Capital Management deployed $21.2M of net new capital in Q3 2026, opening 18 new positions and adding to 47 existing holdings. Its largest new stake was Madrigal Pharmaceuticals: 20,095 shares worth $10.1M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Okta, an estimated $12M trimmed.
- Bourgeon Capital Management's largest Q3 2026 buy was Madrigal Pharmaceuticals: 20,095 shares worth $10.1M.
- Bourgeon Capital Management added most to NXP Semiconductors in Q3 2026, an estimated $5.88M increase.
- Bourgeon Capital Management's biggest Q3 2026 reduction was Okta, cutting an estimated $12M.
- Bourgeon Capital Management fully exited Illumina in Q3 2026, selling an estimated $3.45M.
- Bourgeon Capital Management's ten largest holdings make up 36% of its $696M portfolio in Q3 2026.
- Bourgeon Capital Management opened 18 new positions and closed 9 in Q3 2026.
- Bourgeon Capital Management's portfolio value rose 2.5% quarter-over-quarter to $696M.
Based on Bourgeon Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.